Skip to main content
. 2021 May 26;13(11):2596. doi: 10.3390/cancers13112596

Figure 4.

Figure 4

Representative images of (A) an 81-year-old male patient treating a scalp transplant with a PHBE patch, (B) an 80-year-old female patient treating a cheek with a PHBE patch, (C) an 82-year-old male patient treating the nose and nasal tip with the reference product, and (D) a 58-year-old male patient treating the cheek and alar nasal sulcus with the reference product before RT (Day 0); during Days 7, 14, 21, and 28; and 1 month after RT (Day 60). In contrast to the reference cream, the PHBE patch demonstrated significant anti-inflammatory efficacy.